IMPACT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION ON DIABETES RELATED COMPLICATIONS AND ASSOCIATED COSTS IN TYPE 2 DIABETES PATIENTS IN FINLAND

被引：0
|
作者：
Roze, S. [1 ]
Delbaere, A. [2 ]
de Portu, S. [2 ]
Bjornstrom, K. [3 ]
Honkasalo, M. [4 ]
机构：
[1] Heva Heor Sarl, Hlth Econ, Lyon, France
[2] Medtron Int Sarl, Diabet, Tolochenaz, Switzerland
[3] Medtronic, Medtron Finland, Vantaa, Finland
[4] Nurmijarvi Hlth Ctr, Diabetol Ward, Nurmijarvi, Finland
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
057
引用
收藏
页码：A27 / A28
页数：2
相关论文
共 50 条
  • [41] Factors associated with successful continuous subcutaneous insulin infusion therapy in type 2 diabetes patients - the OPT2MISE trial
    Cohen, O.
    Reznik, Y.
    Conget, I.
    Aronson, R.
    Castaneda, J.
    Huang, S.
    Lee, S.
    Shin, J.
    DIABETOLOGIA, 2014, 57 : S412 - S412
  • [42] Comparison of continuous subcutaneous insulin infusion and multiple daily insulin injections in Chinese patients with type 2 diabetes mellitus
    Yang, Honghong
    Heng, Xueyuan
    Liang, Cuige
    Liu, Xiaomeng
    Du, Wenhua
    Li, Shoujie
    Wang, Yueli
    Dong, Qingyu
    Li, Wenxia
    Pan, Zhenyu
    Gong, Qian
    Gao, Guanqi
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (04) : 1002 - 1010
  • [43] Insulin aspart (IAsp) is as effective in continuous subcutaneous insulin infusion as in multiple daily injections for patients with type 2 diabetes
    Raskin, P
    Bode, B
    Marks, JB
    Hirsch, IB
    Weinstein, R
    McGill, J
    Peterson, G
    Mudaliar, SR
    Reinhardt, R
    DIABETES, 2001, 50 : A128 - A128
  • [44] Investigation of the Insulin Dose and Characteristics of Continuous Subcutaneous Insulin Infusion in Chinese People with Type 2 Diabetes
    Gao, Guan-Qi
    Dong, Qing-Yu
    Li, Shou-Jie
    Zhang, Yuan-Yuan
    Li, Wen-Xia
    Du, Wen-Hua
    Liang, Cui-Ge
    Wang, Yue-Li
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (11) : 1135 - 1138
  • [45] Continuous subcutaneous insulin infusion (CSII) using an external insulin pump for the treatment of type 2 diabetes
    Reznik, Y.
    DIABETES & METABOLISM, 2010, 36 (06) : 415 - 421
  • [46] The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes
    Johnson, Susan L.
    McEwen, Laura N.
    Newton, Christopher A.
    Martin, Catherine L.
    Raskin, Philip
    Halter, Jeffrey B.
    Herman, William H.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2011, 25 (04) : 211 - 215
  • [47] Nocturnal hypoglycemia is not inevitable in type 1 diabetes patients on continuous subcutaneous insulin infusion (CSII)
    Devries, J
    Masurel, N
    Poscia, A
    Heine, R
    DIABETES, 2003, 52 : A92 - A92
  • [48] Retinopathy status in patients with Type 1 diabetes pre and post continuous subcutaneous insulin infusion
    May, C. J.
    Hamada, M.
    Shayovitz, V.
    Dyer, P.
    Teh, M.
    Karamat, A.
    Syed, A.
    DIABETIC MEDICINE, 2013, 30 : 183 - 183
  • [49] Management of cardiovascular risk factors in patients with Type 1 diabetes on continuous subcutaneous insulin infusion
    May, C. J.
    John, R.
    Syed, A.
    DIABETIC MEDICINE, 2013, 30 : 88 - 88
  • [50] TEMPORARY USE OF GLUCOSE SENSORS IN TYPE 1 DIABETES PATIENTS ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    Zivkovic, M.
    Petrovski, G.
    Stratrova, S. Shubeska
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A147 - A147
12345